Aprea Therapeutics GAAP EPS of -$0.07 beats by $0.16
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
600+ sources. One page. See who else covered it.
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
The Tokyo-based company wants to open a U.S. office within a year and list on a U.S. exchange by around 2031
When a patient repeatedly refuses the same medicine, there are usually three possibilities: he does not understand the diagnosis, cannot afford the treatment, or does not trust the doctor.
Wang Quanzhong, director of the NBS Department of Trade and External Economic Relations Statistics, said the combined effects of various policies to boost consumption have continued to take hold this…